These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 36547711)
1. Parosmia as a predictor of a better olfactory function in COVID-19: a multicentric longitudinal study for upper respiratory tract infections. Menzel S; Haehner A; Woosch D; Marquardt B; Ressel C; Draf J; Ottaviano G; Boscolo-Rizzo P; Kardashi R; de With K; Hackl Y; Hummel T Eur Arch Otorhinolaryngol; 2023 May; 280(5):2331-2340. PubMed ID: 36547711 [TBL] [Abstract][Full Text] [Related]
2. Parosmia in patients with post-infectious olfactory dysfunction in the era of COVID-19-associated olfactory impairment. Gunder N; Hummel T HNO; 2024 Sep; 72(9):649-656. PubMed ID: 38935276 [TBL] [Abstract][Full Text] [Related]
4. Parosmia is Associated with Relevant Olfactory Recovery After Olfactory Training. Liu DT; Sabha M; Damm M; Philpott C; Oleszkiewicz A; Hähner A; Hummel T Laryngoscope; 2021 Mar; 131(3):618-623. PubMed ID: 33210732 [TBL] [Abstract][Full Text] [Related]
5. Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics. Cantone E; D'Ascanio L; De Luca P; Roccamatisi D; La La Mantia I; Brenner MJ; Di Stadio A Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3671-3678. PubMed ID: 38492007 [TBL] [Abstract][Full Text] [Related]
6. Prevalence and 24-month recovery of olfactory dysfunction in COVID-19 patients: A multicentre prospective study. Lechien JR; Vaira LA; Saussez S J Intern Med; 2023 Jan; 293(1):82-90. PubMed ID: 36000469 [TBL] [Abstract][Full Text] [Related]
7. Subjective Perception of Recovery and Measured Olfactory Function in COVID-19 Patients. Cancellieri E; Hernandez AK; Degkwitz H; Kahre E; Blankenburg J; Horst TS; Czyborra P; Boscolo-Rizzo P; Hummel T Viruses; 2023 Jun; 15(7):. PubMed ID: 37515106 [TBL] [Abstract][Full Text] [Related]
8. Trigeminal function in patients with COVID-associated olfactory loss. Juratli JH; Garefis K; Konstantinidis I; Hummel T Eur Arch Otorhinolaryngol; 2024 May; 281(5):2403-2411. PubMed ID: 38127097 [TBL] [Abstract][Full Text] [Related]
9. Modified Olfactory Training Is an Effective Treatment Method for COVID-19 Induced Parosmia. Altundag A; Yilmaz E; Kesimli MC Laryngoscope; 2022 Jul; 132(7):1433-1438. PubMed ID: 35257391 [TBL] [Abstract][Full Text] [Related]
10. Recovery of olfactory function following closed head injury or infections of the upper respiratory tract. Reden J; Mueller A; Mueller C; Konstantinidis I; Frasnelli J; Landis BN; Hummel T Arch Otolaryngol Head Neck Surg; 2006 Mar; 132(3):265-9. PubMed ID: 16549746 [TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and associated factors of qualitative olfactory dysfunction. Eo TS; Lee HY; Cho HJ; Yoon JH; Rha MS; Kim CH Rhinology; 2023 Oct; 61(5):432-440. PubMed ID: 37243721 [TBL] [Abstract][Full Text] [Related]
12. Nasal thallium-201 uptake in patients with parosmia with and without hyposmia after upper respiratory tract infection. Shiga H; Okuda K; Taki J; Watanabe N; Tonami H; Kinuya S; Miwa T Int Forum Allergy Rhinol; 2019 Nov; 9(11):1252-1256. PubMed ID: 31356735 [TBL] [Abstract][Full Text] [Related]
13. A study on the prognostic significance of qualitative olfactory dysfunction. Reden J; Maroldt H; Fritz A; Zahnert T; Hummel T Eur Arch Otorhinolaryngol; 2007 Feb; 264(2):139-44. PubMed ID: 17006637 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Patient Characteristics and Olfactory Sensitivity for Trigger Odorants in Parosmia and Phantosmia. Sekine R; Hernandez AK; Overbeck C; Hofer MK; Mori E; Hähner A; Hummel T Laryngoscope; 2024 Jul; 134(7):3277-3285. PubMed ID: 38578016 [TBL] [Abstract][Full Text] [Related]
15. Intranasal insulin for COVID-19-related smell loss. Daniel D; Paula LN; Eduardo BM; Daniel GA; Andrea DE; Fernando LN; Armando MC Eur Arch Otorhinolaryngol; 2024 Jan; 281(1):201-205. PubMed ID: 37608216 [TBL] [Abstract][Full Text] [Related]
16. Olfactory training for patients with olfactory loss after upper respiratory tract infections. Geißler K; Reimann H; Gudziol H; Bitter T; Guntinas-Lichius O Eur Arch Otorhinolaryngol; 2014 Jun; 271(6):1557-62. PubMed ID: 24096819 [TBL] [Abstract][Full Text] [Related]
17. Well-being in patients with olfactory dysfunction. Mai Y; Menzel S; Cuevas M; Haehner A; Hummel T Physiol Behav; 2022 Oct; 254():113899. PubMed ID: 35809697 [TBL] [Abstract][Full Text] [Related]
19. Effects of classical olfactory training in patients with COVID-19-related persistent loss of smell. Yaylacı A; Azak E; Önal A; Aktürk DR; Karadenizli A Eur Arch Otorhinolaryngol; 2023 Feb; 280(2):757-763. PubMed ID: 35904631 [TBL] [Abstract][Full Text] [Related]
20. Assessment of postviral qualitative olfactory dysfunction using the short SSParoT in patients with and without parosmia. Sekine R; Menzel S; Hähner A; Mori E; Hummel T Eur Arch Otorhinolaryngol; 2023 Jan; 280(1):469-472. PubMed ID: 36006515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]